ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för galanthamine hydrobromide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

18 träffar

Bibliografisk träff 2024-06-13

Scalable drop-casting construction of light-addressable photoelectrochemical biosensor on laser-induced graphene electrode arrays for high-throughput drug screening.

Zhan C, Zhang J, Hao J, Liu Z, Hu C.

Biosens Bioelectron · journal article · DOI 10.1016/j.bios.2024.116497

Bibliografisk träff 2023-01-28

Studies on pomegranate seed oil enriched galantamine hydrobromide microemulsion: formulation, in vitro antioxidant and neuroprotective potential.

Shrivas M, Khunt D, Shrivas M, Misra M.

Pharm Dev Technol · journal article · DOI 10.1080/10837450.2023.2171433

Bibliografisk träff 2020-08-01

Comparative evaluation of fish oil and butter oil in modulating delivery of galantamine hydrobromide to brain via intranasal route: pharmacokinetic and oxidative stress studies.

Katdare A, Khunt D, Thakkar S, Polaka SN, Misra M.

Drug Deliv Transl Res · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s13346-020-00739-y

Bibliografisk träff 2018-04-04

PVC membrane, coated-wire, and carbon-paste ion-selective electrodes for potentiometric determination of galantamine hydrobromide in physiological fluids.

Abdel-Haleem FM, Saad M, Barhoum A, Bechelany M, Rizk MS.

Mater Sci Eng C Mater Biol Appl · journal article · DOI 10.1016/j.msec.2018.04.001

Bibliografisk träff 2017-08-22

Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action.

Arafa NMS, Ali EHA, Hassan MK.

Chem Biol Interact · comparative study; journal article · DOI 10.1016/j.cbi.2017.08.013

Bibliografisk träff 2016-02-18

[Serious cutaneous reactions to galantamine hydrobromide (Reminyl® and generics)].

Schmutz JL.

Ann Dermatol Venereol · journal article · DOI 10.1016/j.annder.2015.12.008

Bibliografisk träff 2015-06-05

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer's disease.

Woo FY, Basri M, Masoumi HR, Ahmad MB, Ismail M.

Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s80253

Bibliografisk träff 2013-10-01

Determination of galantamine hydrobromide in bulk drug and pharmaceutical dosage form by spectrofluorimetry.

Patel AV, Patel VJ, Patel AV, Dave JB, Patel CN.

J Pharm Bioallied Sci · research-article; journal article · DOI 10.4103/0975-7406.120079

Bibliografisk träff 2011-07-20

Development and in vivo evaluation of novel monolithic controlled release compositions of galantamine hydrobromide as against reservoir technology.

Khatavkar UN, Shimpi SL, Kumar KJ, Deo KD.

Pharm Dev Technol · randomized controlled trial; journal article · DOI 10.3109/10837450.2011.595799

Bibliografisk träff 2011-01-22

Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide.

Marques LA, Maada I, de Kanter FJ, Lingeman H, Irth H, Niessen WM, Giera M.

J Pharm Biomed Anal · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.jpba.2011.01.022

Bibliografisk träff 2011-01-11

Controlled release reservoir mini tablets approach for controlling the drug release of Galantamine Hydrobromide.

Khatavkar UN, Shimpi SL, Kumar KJ, Deo KD.

Pharm Dev Technol · journal article · DOI 10.3109/10837450.2010.546410

Bibliografisk träff 2009-06-23

The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Turan T, Izgi HB, Ozsoy S, Tanrıverdi F, Basturk M, Asdemir A, Beşirli A, Esel E, Sofuoglu S.

Psychiatry Investig · research-article; journal article · DOI 10.4306/pi.2009.6.3.204

Bibliografisk träff 2009-03-01

Bullous pemphigoid precipitated by galantamine hydrobromide.

Diab M, Coloe J, Bechtel MA.

Cutis · journal article; case reports

Bibliografisk träff 2008-10-17

A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease.

Grace J, Amick MM, Friedman JH.

J Neurol Neurosurg Psychiatry · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1136/jnnp.2008.144048

Bibliografisk träff 2004-09-01

Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.

Blacker CV, Greenwood DT, Wesnes KA, Wilson R, Woodward C, Howe I, Ali T.

JAMA · clinical trial; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1001/jama.292.10.1195

Bibliografisk träff 2003-05-01

Antioxidant properties of galantamine hydrobromide.

Traykova M, Traykov T, Hadjimitova V, Krikorian K, Bojadgieva N.

Z Naturforsch C J Biosci · research support, non-u.s. gov't; journal article · DOI 10.1515/znc-2003-5-613

Bibliografisk träff 2003-03-01

Galantamine hydrobromide: an agent for Alzheimer's disease.

Zarotsky V, Sramek JJ, Cutler NR.

Am J Health Syst Pharm · review; journal article · DOI 10.1093/ajhp/60.5.446

Bibliografisk träff 2001-11-01

Galantamine hydrobromide.

Författaruppgift saknas

Am J Health Syst Pharm · journal article · DOI 10.1093/ajhp/58.22.2138